课题基金 / 基金详情

Molecular Research of the Etiology and Treatment of Hypertension

Molecular Research of the Etiology and Treatment of Hypertension
高血压病因及治疗的分子研究
批准号:
04404044
负责人:
OGIHARA Toshio
金额:
$13.12万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (A)
财政年份:
1992
资助国家:
日本
项目状态:
已结题
起止时间:
1992 至 1994

项目摘要

项目成果

OGIHARA Toshio的其他基金

相似基金

相关文献

中文摘要
翻译
为了研究高血压的分子病因学,我们对自发性高血压大鼠(SHR)进行了遗传筛查。到目前为止,我们已经检测到了两个与血压相关的基因:一个是第4染色体上的NPY基因,它引起血压升高;另一个是第8染色体上的PLCdelta1基因,它与降压有关。我们还发现,10号染色体上的血管紧张素转换酶基因与卒中易感自发性高血压大鼠的盐敏感性有关,肾上腺P450;11β基因突变可能与Dahl‘s耐盐大鼠的耐盐性有关。这些结果表明,多个基因的嵌合体有助于血压水平的降低。另一方面,在使用日本人群进行的人类研究中,我们证实了血管紧张素原基因T235突变的意义,该突变已由Jeunemaitre等人在欧洲高加索人中报道。尽管我们没有通过…为了进一步证明血管紧张素转换酶基因的插入/缺失多态性与日本人血压的相关性,我们证明了血管紧张素转换酶基因的缺失多态性不仅是日本人心肌梗死的危险因素,也是日本人经皮腔内血管成形术后再狭窄的潜在危险因素。通过静脉注射特定的人肾素抑制剂使升高的血压恢复正常。接下来,将含有与大鼠血管紧张素原基因互补的寡核苷酸的HVJ-脂质体注射到肝脏中。反义寡聚体与HVJ脂质体复合后,大鼠血压下降。这些结果表明,HVJ-脂质体有可能成为研究肾素-血管紧张素系统的一种很好的工具,并有望成为高血压的一种新的基因治疗方法。较少
英文摘要
To investigate the molecular etiology of hypertension, we have conducted genetic screening of the spontaneously hypertensive rat (SHR). We have detected so far two loci which are related with blood pressure determination : one is the NPY gene on chromosome 4 which induces blood pressure elevation, and the other is the PLCdelta _1 gene on chromosome 8 with hypotensive effect. We also showed that the angiotensin converting enzyme gene on chromosome 10 is related with salt-sensitivity of stroke-prone SHR,and that the mutation of adrenal P450_<11beta> gene may be responsible for the salt-resistance of Dahl's saltresistant rats. These results suggest that the mosaic of multiple genes contributes to the degermination of the blood pressure level.On the other hand, in the human study using Japanese population, we confirmed significance of hypertensinogenic T235 variant of the angiotensinogen gene, which has been formerly reported in European Caucasians by Jeunemaitre et al. Although we failed … More to prove that the insertion/deletion polymorphism of angiotensin-converting enzyme associates with blood pressure in Japanese, we demonstrated that the deletion polymorphism of angiotensin converting enzyme gene could be a potent risk factor for not only myocardial infarction but also restenosis after percutaneous transluminal angioplasty in Japanese subjects.Using an efficient and nontoxic in vivo gene transfer method (HVJ-liposome), we produced a hypertensive model rat that is dependent on human renin. The elevated blood pressure was normalized by the intravenous administration of specific human renin inhibitor. Next, HVJ-liposomes containing oligonucleotide complementary to rat angiotensinogen gene were injected into liver. The blood pressure of the rat treated with HVJ-liposome complexed with antisense oligomer decreased. These results showed that the HVJ-liposome could be potentially a good tool for the study of the renin-angiotensin system and a furture gene therapy for hypertension. Less
期刊论文(28)
专著(0)
科研奖励(0)
会议论文
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Ohishi M.: "Association between deletion polymorphism of the angiotensin converting-enzymegene and left ventricular hypertrophy" New England Journal of Medicine. 331. 1097-1098 (1994)
Ohishi M.:“血管紧张素转换酶基因的缺失多态性与左心室肥大之间的关联”新英格兰医学杂志。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
27
    Identification of the susceptible gene responsible for essential hypertension and establishment of tailored medicine
    • 批准号:
      14207035
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $30.87万
    • 财政年份:
      2002
    • 负责人:
      OGIHARA Toshio
    • 依托单位:
    Identification of genetic factors responsible for the pathogenesis of essential hypertension
    • 批准号:
      13204050
    • 项目类别:
      Grant-in-Aid for Scientific Research on Priority Areas
    • 资助金额:
      $22.78万
    • 财政年份:
      2001
    • 负责人:
      OGIHARA Toshio
    • 依托单位:
    Identification of genetic susceptibility for cardiovascular disease : two large genetic epidemiological study with cohort base
    • 批准号:
      10307018
    • 项目类别:
      Grant-in-Aid for Scientific Research (A).
    • 资助金额:
      $24.26万
    • 财政年份:
      1998
    • 负责人:
      OGIHARA Toshio
    • 依托单位:
    Gene Therapy in the Cardiovascular Disease
    • 批准号:
      09044299
    • 项目类别:
      Grant-in-Aid for international Scientific Research
    • 资助金额:
      $3.71万
    • 财政年份:
      1997
    • 负责人:
      OGIHARA Toshio
    • 依托单位:
    国内基金
    海外基金
    综合医疗机构引入Gene-Xpert MTB/RIF技术早期发现传染性肺结核和耐药肺结核的研究
    Brahma related gene 1/Lamin B1通路在糖尿病肾脏疾病肾小管上皮细胞衰老中的作用
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      10.0万元
    • 批准年份:
      2021
    • 负责人:
      龙海波
    • 依托单位:
    降钙素基因相关肽(Calcitonin gene-related peptide, CGRP)对穴位敏化的调节及机制研究
    • 批准号:
      81873385
    • 项目类别:
      面上项目
    • 资助金额:
      59.0万元
    • 批准年份:
      2018
    • 负责人:
      乔海法
    • 依托单位:
    大白菜花粉发育相关的三个孤基因(Orphan gene)的表达分析与功能鉴定
    • 批准号:
      31601771
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      20.0万元
    • 批准年份:
      2016
    • 负责人:
      董相书
    • 依托单位: